Kisspeptin

Overview

Kisspeptin refers to a family of peptide fragments derived from the 145-amino-acid precursor protein encoded by the KISS1 gene. The biologically active forms include kisspeptin-54 (the full-length C-terminal fragment, also called metastin), kisspeptin-14, kisspeptin-13, and kisspeptin-10 — all sharing the same C-terminal decapeptide sequence required for receptor binding. Kisspeptins signal through a single G protein-coupled receptor known as KISS1R (formerly GPR54).

The KISS1 gene was originally identified in 1996 at Pennsylvania State University as a metastasis suppressor gene in melanoma — hence the alternative name "metastin" for kisspeptin-54. The gene was whimsically named after Hershey's Kisses chocolates, as the lab was located in Hershey, Pennsylvania. However, kisspeptin's role in reproductive biology was not recognized until 2003, when two independent research groups (Seminara et al. and de Roux et al.) reported that loss-of-function mutations in KISS1R caused idiopathic hypogonadotropic hypogonadism (IHH) — a failure of puberty and reproductive function due to GnRH deficiency.

This discovery established kisspeptin-KISS1R signaling as the critical upstream gatekeeper of the hypothalamic-pituitary-gonadal (HPG) axis, controlling the onset of puberty and the maintenance of reproductive function throughout adult life. Kisspeptin neurons in the hypothalamus (primarily in the arcuate nucleus and anteroventral periventricular nucleus) directly innervate and stimulate GnRH neurons, making kisspeptin the most potent known stimulator of GnRH release.

As of 2026, kisspeptin has advanced into clinical trials for fertility applications and is being investigated as an alternative to conventional GnRH-based and gonadotropin-based fertility treatments.

Structure and Sequence

Kisspeptin-10 (minimal active fragment): Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂

• Kisspeptin-54: 54-amino-acid C-terminal fragment of the KISS1 precursor (residues 68-121)
• Kisspeptin-10: The C-terminal 10 amino acids shared by all active kisspeptin forms; sufficient for full KISS1R activation
• Molecular weight: Kisspeptin-54: approximately 5,863 Da; Kisspeptin-10: approximately 1,302 Da
• Receptor: KISS1R (GPR54), a Gq/11-coupled GPCR
• Gene: KISS1, chromosome 1q32.1
• C-terminal amidation: Required for biological activity; the C-terminal Phe-NH₂ is essential for receptor binding
• RF-amide motif: Kisspeptin belongs to the RF-amide peptide family, sharing a C-terminal Arg-Phe-NH₂ motif

Mechanism of Action

Direct GnRH Neuron Stimulation

Kisspeptin is the most potent known activator of GnRH neurons:

• Kisspeptin neurons in the arcuate nucleus (ARC) and anteroventral periventricular nucleus (AVPV) project directly to GnRH neuron cell bodies and terminals
• KISS1R activation on GnRH neurons triggers depolarization and action potential firing
• A single intravenous bolus of kisspeptin produces robust, dose-dependent LH release (reflecting GnRH-stimulated pituitary LH secretion)
• Kisspeptin is approximately 10,000-fold more potent than GnRH in stimulating LH release on a molar basis when administered peripherally

KISS1R Signaling Cascade

KISS1R is a Gq/11-coupled GPCR. Ligand binding activates:

1. Phospholipase C (PLC) — generates IP3 and DAG
2. Intracellular calcium mobilization — IP3-mediated calcium release from ER stores
3. PKC activation — downstream signaling cascade
4. MAPK/ERK pathway — regulation of gene expression
5. Membrane depolarization — through TRPC (transient receptor potential canonical) channel activation in GnRH neurons

Pulse Generator Function (KNDy Neurons)

A critical advance in understanding kisspeptin biology was the identification of KNDy neurons — kisspeptin neurons in the arcuate nucleus that co-express neurokinin B (NKB) and dynorphin:

• Neurokinin B acts as an intra-network stimulatory signal to synchronize KNDy neuron firing
• Dynorphin acts as an inhibitory signal to terminate each pulse
• Kisspeptin is the output signal that drives GnRH release
• Together, these three neuropeptides generate the pulsatile GnRH secretion pattern essential for reproductive function

This KNDy neuron model provides the molecular basis for the long-sought "GnRH pulse generator."

Sex Steroid Feedback Integration

Kisspeptin neurons are the primary site where sex steroid feedback is integrated to regulate the HPG axis:

• Negative feedback: Estrogen and testosterone suppress kisspeptin expression in ARC neurons, reducing GnRH pulse frequency/amplitude
• Positive feedback (females): Estrogen stimulates kisspeptin expression in AVPV neurons, generating the pre-ovulatory GnRH/LH surge essential for ovulation
• GnRH neurons themselves lack estrogen receptor alpha (ERa) — kisspeptin neurons serve as the intermediary that relays sex steroid feedback to the GnRH system

Puberty Gating

Kisspeptin-KISS1R signaling serves as the developmental gate for puberty:

• Kisspeptin expression increases markedly at the onset of puberty
• Gain-of-function mutations in KISS1R cause precocious (early) puberty
• Loss-of-function mutations cause absent puberty (hypogonadotropic hypogonadism)
• Epigenetic regulation of KISS1 gene transcription is implicated in pubertal timing

Research Summary

Pharmacokinetics

• Half-life (kisspeptin-54): Approximately 28 minutes following intravenous administration in humans
• Half-life (kisspeptin-10): Approximately 4 minutes; shorter forms are more rapidly degraded
• Onset of action: LH rise detectable within 10-15 minutes of IV kisspeptin-54 administration
• Peak LH response: Approximately 30-60 minutes post-administration
• Duration of LH elevation: 6-12 hours following a single IV bolus of kisspeptin-54
• Metabolism: Degraded by matrix metalloproteinases (MMP-2, MMP-9) and other serine proteases that cleave within the N-terminal region
• Route dependence: Kisspeptin-54 (longer form) preferred for clinical use due to its longer half-life; kisspeptin-10 used primarily in research settings
• Tachyphylaxis: Continuous kisspeptin exposure can lead to KISS1R desensitization and reduced GnRH/LH output, analogous to (but mechanistically upstream of) GnRH receptor desensitization

Dosing Protocols

The following dosing information is compiled from published research and community discussion for educational purposes only. No FDA-approved human dosing guidelines exist for most research peptides. Always consult a qualified healthcare professional.

Reconstitution

Dosing Schedule

Syringe Measurements (U-100 insulin syringe)

Cycle Guidelines

• Cycle length: 8-12 weeks
• Route: Subcutaneous injection
• Timing: Consistent daily timing; any time of day
• Injection sites: Rotate between abdomen, thighs, and upper arms
• Note: Avoid prolonged continuous use to prevent tachyphylaxis (KISS1R desensitization)

Common Discussion Topics

1. IVF oocyte maturation trigger — Kisspeptin's ability to trigger oocyte maturation while avoiding ovarian hyperstimulation syndrome (OHSS) is its most clinically advanced application
2. Upstream HPG axis control — As the most upstream druggable target in the HPG axis, kisspeptin offers the potential for more physiological reproductive axis modulation than direct GnRH or gonadotropin administration
3. Puberty and development — Kisspeptin's role as the pubertal gatekeeper is a major focus of developmental endocrinology research
4. Comparison with gonadorelin — Kisspeptin stimulates GnRH release from the hypothalamus, while gonadorelin acts directly at the pituitary; this upstream mechanism may better preserve physiological pulsatility
5. Psychosexual effects — Kisspeptin's effects on limbic brain activity and sexual arousal represent an emerging and unique research area
6. Male hypogonadism — Investigation of kisspeptin as a potential treatment for various forms of male hypogonadism, including obesity-related and diabetes-related testosterone deficiency

Related Compounds

• Gonadorelin — the synthetic GnRH that kisspeptin neurons stimulate; acts one level downstream at the pituitary
• Follistatin — regulates FSH through activin antagonism; intersects with the gonadotropin axis
• GnRH agonists (Leuprolide, Goserelin) — act downstream of kisspeptin at the GnRH receptor level
• Neurokinin B (NKB) — co-expressed with kisspeptin in KNDy neurons; NKB receptor antagonists are in development for menopausal hot flashes
• TAK-448/TAK-683 — synthetic kisspeptin analogs with improved pharmacokinetic profiles under pharmaceutical development